Vera Therapeutics Inc (VERA)
45.53
+2.09
(+4.81%)
USD |
NASDAQ |
May 06, 16:00
45.37
-0.16
(-0.35%)
After-Hours: 20:00
Vera Therapeutics Shareholders Equity (Quarterly): 101.68M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.68M |
| September 30, 2023 | 123.71M |
| June 30, 2023 | 140.52M |
| March 31, 2023 | 157.71M |
| December 31, 2022 | 76.91M |
| September 30, 2022 | 105.72M |
| June 30, 2022 | 121.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 134.42M |
| December 31, 2021 | 69.59M |
| September 30, 2021 | 85.48M |
| June 30, 2021 | 92.16M |
| March 31, 2021 | -93.32M |
| December 31, 2020 | -89.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-93.32M
Minimum
Mar 2021
157.71M
Maximum
Mar 2023
78.98M
Average
101.68M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 17.58B |
| Alpine Immune Sciences Inc | 327.94M |
| Fate Therapeutics Inc | 368.42M |
| Mersana Therapeutics Inc | 36.90M |
| Equillium Inc | 22.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 175.55M |
| Total Liabilities (Quarterly) | 73.86M |